NCT04122547

Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis

Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis: a Randomized Double-blind Placebo-controlled Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Prince of Songkla University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Roflumilast compare with placebo for decrease infected exacerbation in non-cystic Bronchiectasis

Detailed description

Efficacy and RCT compare roflumilast vs placebo for 6 months in frequent infectious exacerbation in non-cystic bronchiectasis in Thailand

Conditions

• Exacerbation Copd
• Bronchiectasis
• Lung Function Decreased

Interventions

Type	Name	Description
DRUG	Roflumilast	Active drug
DRUG	Placebo	Placebo one tablet oral od

Timeline

• Start date: 2015-01-01
• Primary completion: 2015-12-01
• Completion: 2015-12-01
• First posted: 2019-10-10
• Last updated: 2019-10-10

Locations

1 site across 1 country: Thailand